Image

Interest of Hypnosis When Setting up Non-invasive Ventilation in a Conscious Patient With COPD and/or Obesity With a BMI Greater Than 30, Suffering Fromacute Respiratory Distress in Adult Intensive Care

Interest of Hypnosis When Setting up Non-invasive Ventilation in a Conscious Patient With COPD and/or Obesity With a BMI Greater Than 30, Suffering Fromacute Respiratory Distress in Adult Intensive Care

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Discomfort during respiratory decompensation of a patient with chronic obstructive pulmonary disease (COPD) and/or obesity with a BMI greater than 30, in intensive care and the establishment of non-invasive ventilation (NIV) is frequent and a source of failure. this therapy. Pharmacological treatments may be impossible due to the pathology, the risk of it worsening and adverse effects. In this context, hypnosis appears to be a tool that would promote comfort and thus increase tolerance of NIV.

Eligibility

Pre-inclusion criteria

  • Man or woman, aged 18 or over, admitted to medical intensive care
  • Glasgow score = 15
  • Patient with acute respiratory failure decompensating COPD and/or having obesity with a body mass index (BMI) greater than 30
  • Patient having given free, informed and written consent
  • Patient affiliated to a health insurance system

Inclusion Criteria:

  • Glasgow score = 15
  • Need during use of non-invasive ventilation

Exclusion Criteria:

  • Procedure to be carried out in extreme urgency (PaCO2 too high and leading to an immediate vital risk, and / or PaO2 too low) on medical decision
  • Confusional state making hypnosis impossible
  • Decompensated psychiatric illness
  • Patient entering with an NIV in place already installed in another department. The subject becomes included again at the end of the treatment with NIV if however he needs it again.
  • Patient already included in the study during previous non-invasive ventilation
  • Patient participating in research involving an interventional human person (category
    1. on an analgesic / sedative medication
  • A person of full age subject to legal protection (safeguard of justice, curators,

    guardianship) or deprived of liberty

Study details
    Chronic Obstructive Pulmonary Disease (COPD)
    Obesity With a BMI Greater Than 30
    Acute Respiratory Distress in Adult Intensive Care

NCT04220463

Rennes University Hospital

3 July 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.